MYGN

Myriad Genetics Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 0/10
  • Value↓ 1/10
Myriad Genetics sales and earnings growth
MYGN Growth
Low
  • Revenue Y/Y↓ -2.62%
  • EPS Y/Y↓ -283.04%
  • FCF Y/Y↑ 35.20%
Myriad Genetics gross and profit margin trends
MYGN Profitability
Low
  • Gross margin ↑ 70.00%
  • EPS margin↓ -48.20%
  • ROIC 5Y↓ -65.98%
Myriad Genetics net debt vs free cash flow
MYGN Risk
Great
  • Debt / Equity↓ 0.6
  • Debt / FCF↓ 3.8
  • Interest coverage↓ -28.0

Myriad Genetics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Diagnostics & Research stocks